1. Home
  2. IMMP vs CRMT Comparison

IMMP vs CRMT Comparison

Compare IMMP & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • CRMT
  • Stock Information
  • Founded
  • IMMP 1987
  • CRMT 1981
  • Country
  • IMMP Australia
  • CRMT United States
  • Employees
  • IMMP N/A
  • CRMT N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • CRMT Other Specialty Stores
  • Sector
  • IMMP Health Care
  • CRMT Consumer Discretionary
  • Exchange
  • IMMP Nasdaq
  • CRMT Nasdaq
  • Market Cap
  • IMMP 251.8M
  • CRMT 266.5M
  • IPO Year
  • IMMP N/A
  • CRMT N/A
  • Fundamental
  • Price
  • IMMP $1.97
  • CRMT $25.45
  • Analyst Decision
  • IMMP Buy
  • CRMT Buy
  • Analyst Count
  • IMMP 1
  • CRMT 1
  • Target Price
  • IMMP $7.00
  • CRMT $45.00
  • AVG Volume (30 Days)
  • IMMP 120.6K
  • CRMT 184.6K
  • Earning Date
  • IMMP 10-10-2025
  • CRMT 09-04-2025
  • Dividend Yield
  • IMMP N/A
  • CRMT N/A
  • EPS Growth
  • IMMP N/A
  • CRMT N/A
  • EPS
  • IMMP N/A
  • CRMT 1.61
  • Revenue
  • IMMP $3,306,742.00
  • CRMT $1,378,681,000.00
  • Revenue This Year
  • IMMP $16.82
  • CRMT $3.49
  • Revenue Next Year
  • IMMP N/A
  • CRMT $5.72
  • P/E Ratio
  • IMMP N/A
  • CRMT $16.46
  • Revenue Growth
  • IMMP 31.28
  • CRMT 0.64
  • 52 Week Low
  • IMMP $1.32
  • CRMT $25.93
  • 52 Week High
  • IMMP $2.71
  • CRMT $62.72
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 63.51
  • CRMT 23.90
  • Support Level
  • IMMP $1.75
  • CRMT $28.33
  • Resistance Level
  • IMMP $2.10
  • CRMT $30.75
  • Average True Range (ATR)
  • IMMP 0.09
  • CRMT 1.41
  • MACD
  • IMMP 0.03
  • CRMT -0.00
  • Stochastic Oscillator
  • IMMP 74.79
  • CRMT 2.57

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: